Turning Point Therapeutics Inc TPTX:

*Data is delayed
Last | EST
()
52 week range
23.77 - 82.20
Loading...
  • Open-
  • Day High-
  • Day Low-
  • Prev Close-
  • 52 Week High82.20
  • 52 Week High Date09/02/21
  • 52 Week Low23.77
  • 52 Week Low Date03/15/22

Key Stats

  • Market Cap3,761.33M
  • Shares Out50.07M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.20
  • YTD % Change59.35

KEY STATS

  • Open-
  • Day High-
  • Day Low-
  • Prev Close-
  • 52 Week High82.20
  • 52 Week High Date09/02/21
  • 52 Week Low23.77
  • 52 Week Low Date03/15/22
  • Market Cap3,761.33M
  • Shares Out50.07M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.20
  • YTD % Change59.35

RATIOS/PROFITABILITY

  • EPS (TTM)-6.90
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-343.055M
  • ROE (TTM)-36.80%
  • Revenue (TTM)1.01M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-33,959.03%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Turning Point Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Turning Point Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in designing and developing therapies that target genetic drivers of cancer to improve the lives of patients. It develops a macrocycle platform from which it designs its pipeline of small, compact tyrosine kinase inhibitors (TKIs). The TKIs generated from its drug discovery platform address unmet needs in TKI naive and resistance settings. The Company’s drug candidate...
Mark Alles
Independent Chairman of the Board
Athena Countouriotis M.D.
President, Chief Executive Officer, Director
Paolo Tombesi
Chief Financial Officer, Executive Vice President
Andrew Partridge
Executive Vice President , Chief Commercial Officer
Mohammad Hirmand M.D.
Executive Vice President, Chief Medical Officer
Address
10628 Science Center Drive, Suite 200
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
CCXI
ChemoCentryx Inc
50.78-0.08-0.16%
FATE
Fate Therapeutics Inc
30.21-2.69-8.18%
ROIV
Roivant Sciences Ltd
4.04-0.09-2.18%
ZLAB
Zai Lab Ltd
43.52-2.04-4.48%
CYTK
Cytokinetics Inc
50.57-0.24-0.47%